AAFMAA Wealth Management & Trust LLC Raises Stake in VanEck Pharmaceutical ETF (NASDAQ:PPH)

AAFMAA Wealth Management & Trust LLC boosted its stake in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) by 3.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 36,419 shares of the company’s stock after buying an additional 1,100 shares during the quarter. VanEck Pharmaceutical ETF makes up 1.4% of AAFMAA Wealth Management & Trust LLC’s portfolio, making the stock its 18th largest position. AAFMAA Wealth Management & Trust LLC owned 0.57% of VanEck Pharmaceutical ETF worth $3,142,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently added to or reduced their stakes in the stock. Total Clarity Wealth Management Inc. lifted its holdings in shares of VanEck Pharmaceutical ETF by 59.5% in the 2nd quarter. Total Clarity Wealth Management Inc. now owns 10,718 shares of the company’s stock worth $980,000 after buying an additional 3,998 shares during the period. Renaissance Technologies LLC lifted its stake in VanEck Pharmaceutical ETF by 85.0% in the second quarter. Renaissance Technologies LLC now owns 25,900 shares of the company’s stock worth $2,369,000 after acquiring an additional 11,902 shares during the period. Blair William & Co. IL grew its holdings in VanEck Pharmaceutical ETF by 15.4% during the 2nd quarter. Blair William & Co. IL now owns 6,941 shares of the company’s stock worth $635,000 after acquiring an additional 924 shares in the last quarter. Thrivent Financial for Lutherans bought a new position in VanEck Pharmaceutical ETF during the 2nd quarter worth about $16,088,000. Finally, Beck Capital Management LLC increased its position in VanEck Pharmaceutical ETF by 1.5% during the 2nd quarter. Beck Capital Management LLC now owns 21,274 shares of the company’s stock valued at $1,946,000 after purchasing an additional 317 shares during the period.

VanEck Pharmaceutical ETF Stock Performance

NASDAQ:PPH opened at $86.31 on Tuesday. The firm has a 50-day simple moving average of $88.36 and a 200-day simple moving average of $92.33. VanEck Pharmaceutical ETF has a one year low of $83.60 and a one year high of $99.51. The firm has a market cap of $555.84 million, a P/E ratio of 21.04 and a beta of 0.72.

VanEck Pharmaceutical ETF Increases Dividend

The business also recently announced a dividend, which was paid on Monday, December 30th. Shareholders of record on Friday, December 27th were issued a dividend of $0.411 per share. The ex-dividend date of this dividend was Friday, December 27th. This is a positive change from VanEck Pharmaceutical ETF’s previous dividend of $0.36.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.